- Home
- ELMD vs VYGR Comparison
ELMD vs VYGR Comparison
Compare ELMD & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELMD
- VYGR
- Stock Information
- Founded
- ELMD 1992
- VYGR 2013
- Country
- ELMD United States
- VYGR United States
- Employees
- ELMD N/A
- VYGR N/A
- Industry
- ELMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- VYGR Biotechnology: Pharmaceutical Preparations
- Sector
- ELMD Health Care
- VYGR Health Care
- Exchange
- ELMD Nasdaq
- VYGR Nasdaq
- Market Cap
- ELMD 190.6M
- VYGR 156.0M
- IPO Year
- ELMD 2010
- VYGR 2015
- Fundamental
- Price
- ELMD $20.54
- VYGR $2.97
- Analyst Decision
- ELMD Strong Buy
- VYGR Strong Buy
- Analyst Count
- ELMD 1
- VYGR 8
- Target Price
- ELMD $38.00
- VYGR $14.33
- AVG Volume (30 Days)
- ELMD 51.9K
- VYGR 841.7K
- Earning Date
- ELMD 05-13-2025
- VYGR 08-05-2025
- Dividend Yield
- ELMD N/A
- VYGR N/A
- EPS Growth
- ELMD 60.99
- VYGR N/A
- EPS
- ELMD 0.79
- VYGR N/A
- Revenue
- ELMD $61,439,000.00
- VYGR $66,958,000.00
- Revenue This Year
- ELMD $17.91
- VYGR N/A
- Revenue Next Year
- ELMD $11.70
- VYGR $78.88
- P/E Ratio
- ELMD $25.74
- VYGR N/A
- Revenue Growth
- ELMD 14.85
- VYGR N/A
- 52 Week Low
- ELMD $13.74
- VYGR $2.65
- 52 Week High
- ELMD $35.56
- VYGR $9.55
- Technical
- Relative Strength Index (RSI)
- ELMD 50.64
- VYGR 41.86
- Support Level
- ELMD $20.00
- VYGR $3.24
- Resistance Level
- ELMD $20.39
- VYGR $3.64
- Average True Range (ATR)
- ELMD 0.57
- VYGR 0.27
- MACD
- ELMD 0.15
- VYGR -0.02
- Stochastic Oscillator
- ELMD 74.54
- VYGR 6.17
About ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.